Leonard L. Mazur - Jul 22, 2021 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role: Executive Chairman, Director, 10%+ Owner
Signature: /s/ Alexander M. Donaldson, by power of attorney
Stock symbol: CTXR
Transactions as of: Jul 22, 2021
Transactions value $: $0
Form type: 4
Date filed: 7/26/2021, 05:02 PM
Next filing: Oct 13, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CTXR	Common Stock						10.3M	Jul 22, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTXR	Options to Purchase Common Stock	Award	$0	+300K		$0.00	300K	Jul 22, 2021	Common Stock	300K	$2.00	Direct	F7
holding	CTXR	Options to Purchase Common Stock						40K	Jul 22, 2021	Common Stock	40K	$3.45	Direct	F1
holding	CTXR	Warrant to Purchase Common Stock						421K	Jul 22, 2021	Common Stock	421K	$4.13	Direct	F2
holding	CTXR	Warrant to Purchase Common Stock						11K	Jul 22, 2021	Common Stock	11K	$4.13	Direct	F2
holding	CTXR	Options to Purchase Common Stock						220K	Jul 22, 2021	Common Stock	220K	$6.75	Direct	F3
holding	CTXR	Warrant to Purchase Common Stock						107K	Jul 22, 2021	Common Stock	107K	$4.63	Direct	F2
holding	CTXR	Warrant to Purchase Common Stock						168K	Jul 22, 2021	Common Stock	168K	$2.86	Direct	F2
holding	CTXR	Warrant to Purchase Common Stock						3.14M	Jul 22, 2021	Common Stock	3.14M	$1.15	Direct	F2
holding	CTXR	Options to Purchase Common Stock						150K	Jul 22, 2021	Common Stock	150K	$1.62	Direct	F4
holding	CTXR	Warrant to Purchase Common Stock						1.62M	Jul 22, 2021	Common Stock	1.17M	$1.42	Direct	F2
holding	CTXR	Warrant to Purchase Common Stock						2.23M	Jul 22, 2021	Common Stock	2.23M	$0.77	Direct	F2
holding	CTXR	Options to Purchase Common Stock						175K	Jul 22, 2021	Common Stock	175K	$0.67	Direct	F5
holding	CTXR	Options to Purchase Common Stock						200K	Jul 22, 2021	Common Stock	200K	$1.01	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest, provided the Reporting Person continues to serve as a member of the Company's Board of Directors as of each such vesting date.
F2	The warrant is fully vested and exercisable immediately.
F3	The option vested as to 40% of the shares of the Company's common stock on September 12, 2014 and 15% of the shares on each of September 12, 2015, March 12 and September 12, 2016 and September 12, 2017.
F4	One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.
F5	The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F6	The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F7	The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.